Cellectis SA(CLLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CLLS Cellectis SA

Post-Mkt 07-31 17:19:14 EDT

2.75

-0.10

-3.51%

盘后2.75

+0.000.00%

16:04 EDT

High2.85	Low2.67	Vol12.72K
Open2.85	D1 Closing2.85	Amplitude6.32%
Mkt Cap277.75M	Tradable Cap205.43M	Total Shares101.00M
T/O35.52K	T/O Rate0.02%	Tradable Shares74.70M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CLLS","market":"US","secType":"STK","nameCN":"Cellectis SA","latestPrice":2.75,"timestamp":1785528000000,"preClose":2.85,"halted":0,"volume":12724,"hourTrading":{"tag":"盘后","latestPrice":2.75,"preClose":2.75,"latestTime":"16:04 EDT","volume":108,"amount":297,"timestamp":1785528292862,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03508771929824565,"floatShares":74700400,"shares":101000000,"eps":-0.670046,"marketStatus":"Post-Mkt","change":-0.1,"latestTime":"07-31 17:19:14 EDT","open":2.85,"high":2.85,"low":2.67,"amount":35519,"amplitude":0.063158,"askPrice":3.11,"askSize":100,"bidPrice":2.29,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.670046,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1785542400000},"marketStatusCode":4,"adr":1,"adrRate":1,"listingDate":1427256000000,"exchange":"NASDAQ","adjPreClose":2.85,"postHourTrading":{"tag":"盘后","latestPrice":2.75,"preClose":2.75,"latestTime":"16:04 EDT","volume":108,"amount":297,"timestamp":1785528292862,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.127055,"impliedVol":0.0543,"impliedVolPercentile":0.0996},"requestUrl":"/m/hq/s/CLLS","defaultTab":"news","newsList":[{"id":"2655364296","title":"Cellectis SA Expected to Post a Loss of 26 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2655364296","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655364296?lang=en_us&edition=fundamental","pubTime":"2026-07-31 22:02","pubTimestamp":1785506536,"startTime":"0","endTime":"0","summary":"Cellectis SA <CLLS.OQ> expected to post a loss of26cents a share - Earnings PreviewCellectis SACLLS.OQ,CLLS.Ois expected to  show a fall in quarterly revenue when it reports  results on August 6 for t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X255:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655386414","title":"Cellectis to Report Second Quarter Financial Results on August 6, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655386414","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655386414?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:30","pubTimestamp":1785443400,"startTime":"0","endTime":"0","summary":"NEW YORK, July  30, 2026  (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to dev","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/30/3336464/0/en/Cellectis-to-Report-Second-Quarter-Financial-Results-on-August-6-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653769130","title":"European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2653769130","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653769130?lang=en_us&edition=fundamental","pubTime":"2026-07-22 23:10","pubTimestamp":1784733024,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.69% to 1,924.81 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and petroleum refiner Equinor , which climbed 6.8% and 4.9%, respectively. They were followed by semiconductor company Sequans Communications  and brewing company Anheuser-Busch InBev , which advanced 4% and 2.8%, respectively.The decliners from continental Europe were led by internet browser company Opera  and biopharmaceutical company DBV Technologies , which dropped 3.3% and 2.9%, respectively. They were followed by telecommunications company Nokia  and software firm SAP , which lost 2.6% and 2%, respectively.The gainers from the UK were led by biopharmaceutical firm Akari Therapeutics  and insurance firm Prudential , which rose 6.6% and 3.4%, respectively. They were followed by lender HSBC  and telecommunications company operato","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","SAP","BK4139","IE00BMPRXN33.USD","BK4162","LNOK","BUD.AU","BDRX","TRIB","LU0052756011.USD","EQNR","SLN","BK4117","VOD","BK4588","LU0128525689.USD","LU0211326755.USD","BK4521","BK4132","PSO","BK4532","LFGY","BK4141","SQNS","BK4201","EPV","BK4107","BK4207","BK4023","CLLS","PUK","BK4528","LU0211326839.USD","BUD","DBVT","HSBC","BK4158","IE00BMPRXR70.SGD","HSBH","NOK","AKTX","BK4204","LU0310800965.SGD","BK4020","IEUR","OPRA","LU0976567544.SGD","AFG","LU0496365809.HKD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649992507","title":"European Equities Traded in the US as American Depositary Receipts Decline Sharply in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2649992507","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649992507?lang=en_us&edition=fundamental","pubTime":"2026-07-08 23:09","pubTimestamp":1783523397,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Wednesday morning, falling 1.11% to 1,892.74 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor  and oil and gas company Eni , which rose 2.4% each. They were followed by accommodations booking site trivago  and pharmaceutical company Ascendis Pharma , which gained 1.7% and 0.7%, respectively.The decliners from continental Europe were led by lender Banco Santander  and software company SAP , which fell 5.1% and 3.7%, respectively. They were followed by internet advertising company Criteo  and biopharmaceutical company Cellectis , which declined 3.5% and 1.1%, respectively.The gainers from the UK were led by oil and gas company BP  and biotech company Autolus Therapeutics , which advanced 1.7% and 1.6%, respectively. They were followed by telecommunications company Vodafone Group  and educational publisher Pearson , which each gained 0.5%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WPP.AU","VDE","PXJ","CLLS","BK4521","LU0006061336.USD","DBC","LU0162691827.USD","DIG","BP","DBE","ASND","DRIP","SLN","PSO","IEUR","CRTO","BK4009","BK4201","WPP","MEDI","BK4204","BK4139","IEO","TRIB","BK4107","FTXN","VOD","AKTX","BK4111","SAP","IXC","ERX","BK4585","PXE","TRVG","EQNR","EPV","E","SAN.AU","USE","GSIB","SAN","XES","GUSH","AFG","WTIU","AUTL","DRLL","BPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648268984","title":"European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2648268984","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648268984?lang=en_us&edition=fundamental","pubTime":"2026-07-02 23:13","pubTimestamp":1783005214,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were sharply higher late Thursday morning, advancing 2.21% to 1,927.62 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and biotech firm Evaxion , which climbed 14% and 6.9% respectively. They were followed by biotech company BioNTech  and biopharmaceutical company DBV Technologies , which advanced 4.5% and 4.1% respectively.The only decliners from continental Europe were telecommunications company Nokia  and medical device maker EDAP , which were down 1% and 0.8% respectively.The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics  and NuCana , which rose 8.6% and 6.6% respectively. They were followed by biotech firm Autolus Therapeutics  and pharmaceutical company Silence Therapeutics , which were up 4.8% and 3.7% respectively.The only decliners from the UK and Ireland were biopharmaceutical companies Biodexa Pharmaceuti","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLN","LU0006061336.USD","CLLS","LNOK","AMRN","BK4585","BK4548","BK4547","AKTX","IE00BMPRXR70.SGD","IEUR","NOK","BK4568","BDRX","BNTX","EPV","NCNA","BK4117","AFG","DBVT","BK4139","BK4082","BK4588","BK4020","AUTL","FOCL","EVAX","IE00BMPRXN33.USD","BK4107","BK4535","BK4551","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647728308","title":"European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2647728308","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647728308?lang=en_us&edition=fundamental","pubTime":"2026-06-29 23:11","pubTimestamp":1782745882,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Monday morning, rising 0.60% to 1,888.94 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies Cellectis  and DBV Technologies , which advanced 6% and 2.7% respectively. Also rising were internet advertising firm Criteo  and biotech company Evaxion , which increased 3.6% and 6.3% respectively.The decliners from continental Europe were led by telecommunications operator Nokia  and medical device maker EDAP TMS , which fell 2.8% and 1% respectively.  Anheuser-Busch InBev, which was off 1.2%.The gainers from the UK were led by biopharmaceutical company NuCana  and software firm Endava , which rose 3.2% and 2.5% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group  and oil and gas company BP , which were up 1.4% and 1.1% respectively.The decliners from the UK and Ireland were led by biopharmaceutical companies ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NCNA","BK4007","BK4134","BK4107","CRTO","LU0320765646.SGD","IE00BMPRXR70.SGD","BK4547","IEUR","BK4588","AMRN","BP","BK4505","EVAX","NOK","BK4020","DBVT","DAVA.AU","BK4009","IE00BMPRXN33.USD","FOCL","AFG","BUD","BK4139","LU0300736492.USD","BK4201","BK7119","MREO","TRIB","IE00BFMHRM44.USD","LU0300736062.USD","BK4117","LU0084288595.USD","BK4158","BK4585","BUD.AU","BPH","CLLS","BK4082","LU0006061336.USD","LU0162691827.USD","DAVA","EPV","LU1162221912.USD","BDRX","LU0648005311.SGD","AKTX","LU0072461881.USD","LU1829250122.USD","LNOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646385011","title":"Press Release: Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2646385011","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646385011?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:30","pubTimestamp":1782419400,"startTime":"0","endTime":"0","summary":"NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Cellectis (the \"Company\") (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to devel","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645060811","title":"European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2645060811","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645060811?lang=en_us&edition=fundamental","pubTime":"2026-06-24 23:15","pubTimestamp":1782314107,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Wednesday morning, falling 0.83% to 1,868.68 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by 3D printer company Materialise  and medical device maker EDAP TMS , which rose 5.5% and 4.8% respectively. They were followed by semiconductor company Sequans Communications  and consumer goods company Unilever , which were up 1.7% and 1.3% respectively.The decliners from continental Europe were led by biopharmaceutical firm Cellectis  and petroleum refiner Equinor , which dropped 5.4% and 3.5% respectively. They were followed by oil and gas company Eni  and telecommunications company Ericsson , which were down 3.1% and 1.8% respectively.The gainers from the UK were led by Silence Therapeutics  and Trinity Biotech , which surged 15% and 9.3% respectively. They were followed by Biodexa Pharmaceuticals  and medical device maker Smith & Nephew , which advanced 4.1% and 2.4% respec","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DRLL","DBC","DIG","MTLS","ULVR.UK","GUSH","DRIP","AUTL","VDE","IXC","BK4141","BK4554","IEUR","BDRX","ERIC","UN","BK4082","SNN","PXE","BK4585","ERX","FTXN","TRIB","LU0006061336.USD","SQNS","WTIU","BK4020","BK4505","AKTX","FOCL","IEO","AFG","LU1829250122.USD","EQNR","BK4546","EPV","SLN","UL","PXJ","BP","DBE","BK4183","E","LU0300736492.USD","CLLS","USE","BPH","XES","BK4592","MREO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645999075","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2645999075","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645999075?lang=en_us&edition=fundamental","pubTime":"2026-06-22 23:06","pubTimestamp":1782140816,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week higher late Monday morning, advancing 0.61% to 1,903.57 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk  and telecommunications company Nokia , which rose 4.5% and 4.2% respectively. They were followed by internet browser company Opera  and biopharmaceutical company DBV Technologies , which were up 2.8% and 1.8% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and pharmaceutical company Sanofi , which fell 5% and 2.8% respectively. They were followed by internet advertising firm Criteo  and semiconductor company Sequans Communications , which were down 2.6% and 2.4% respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics  and biopharmaceutical company Amarin , which advanced 5.7% and 4.6% respectively. They were followed by lenders Lloyds Banking","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BMPRXN33.USD","NVOX","NVO","BK4521","BK4141","BK4020","BK4082","BHP","BK4132","BK4168","AMRN","BK4009","NOK","IE00BFMHRM44.USD","IE00BZ1G4Q59.USD","BK4588","LU0300736492.USD","LU0300736062.USD","NVOH","BK4023","DBVT","SNN","BK4547","LYG","BK4207","LNOK","LU1093756325.SGD","IE00BFXG1179.USD","BK4599","CRTO","OPRA","BK4532","SQNS","LU0154236417.USD","IE00BMPRXR70.SGD","BCS","NCNA","BK4139","SNY","VOD","BK4007","LU0006061336.USD","IE00BKVL7J92.USD","CLLS","LU1093756168.USD","BK4585","SLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642233239","title":"Cellectis Says Phase 1 Lasme-cel Study Shows 100% Response Rate in B-Cell Leukemia Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2642233239","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642233239?lang=en_us&edition=fundamental","pubTime":"2026-06-11 23:57","pubTimestamp":1781193431,"startTime":"0","endTime":"0","summary":"Cellectis (CLLS) said Thursday that data from a phase 1 trial of lasme-cel in relapsed/refractory B-cell acute lymphoblastic leukemia, or r/r B-ALL, reflected strong response and remission rates.The s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642401957","title":"Cellectis Presents Final Phase 1 Results of Lasme-cel and  Preliminary Results on Eti-cel at EHA 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2642401957","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642401957?lang=en_us&edition=fundamental","pubTime":"2026-06-11 14:40","pubTimestamp":1781160000,"startTime":"0","endTime":"0","summary":"NEW YORK, June  11, 2026  (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to de","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/11/3310207/0/en/Cellectis-Presents-Final-Phase-1-Results-of-Lasme-cel-and-Preliminary-Results-on-Eti-cel-at-EHA-2026-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4139","IE0031619046.USD","LU2065731478.USD","BK4161","CRS","IE00B7SZL793.SGD","BK4080","BK4187","CR","BK4231","BK4022","CLLS","ORR","IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4006","CAR","LU0963586101.USD","BK4230","HSCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642249709","title":"Cellectis granted RMAT designation for lasmecabtagene timgedleucel from FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2642249709","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642249709?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:40","pubTimestamp":1781037612,"startTime":"0","endTime":"0","summary":"Cellectis (CLLS) announced that the FDA granted Regenerative Medicine Advanced Therapy, or RMAT, designation to lasmecabtagene timgedleucel, its CD...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cellectis-granted-rmat-designation-for-lasmecabtagene-timgedleucel-from-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cellectis-granted-rmat-designation-for-lasmecabtagene-timgedleucel-from-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","BK4116","CD","BK4127","BK4139","LABU","BK4585","BK4588","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642977644","title":"Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL","url":"https://stock-news.laohu8.com/highlight/detail?id=2642977644","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642977644?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:30","pubTimestamp":1781037000,"startTime":"0","endTime":"0","summary":"NEW YORK, June  09, 2026  (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to de","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/09/3309345/0/en/Cellectis-Receives-FDA-RMAT-Designation-for-lasme-cel-the-First-Allogeneic-CAR-T-Therapy-in-a-Pivotal-Trial-for-Patients-with-r-r-B-ALL.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","BK4022","TX","BK4588","LU0640798160.USD","BK4230","LU2355687059.USD","LU1699723380.USD","IE00B3M56506.USD","BK4139","ALL","LU0985320562.USD","LABU","BK4585","BK4533","CLLS","LU1571399168.USD","BK4006","LU1115378108.SGD","CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642496572","title":"European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2642496572","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642496572?lang=en_us&edition=fundamental","pubTime":"2026-06-09 23:11","pubTimestamp":1781017898,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Tuesday morning, rising 0.80% to 1,882.97 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and semiconductor company Sequans Communications , which rose 3.8% and 3.7% respectively. They were followed by healthcare tech company Royal Philips  and biopharmaceutical company Grifols , which were up 2.9% and 2.5% respectively.The decliners from continental Europe were led by telecommunications company Ericsson  and petroleum refiner Equinor , which dropped 5% and 2.6% respectively. They were followed by telecommunications company Nokia  and SAP , which lost 1.5% and 1% respectively.The gainers from the UK were led by communications company WPP  and biopharmaceutical company Amarin , which advanced 7.9% and 5.6% respectively. They were followed by pharmaceutical company Silence Therapeutics  and biopharmaceutical company Akari Th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLN","PXJ","ERIC","BPH","HSBC","DIG","WPP","USE","LNOK","SQNS","GUSH","ERX","BP","LU0310800965.SGD","WTIU","LU0162691827.USD","DRIP","BK4117","HSBH","WPP.AU","BK4141","AFG","FTXN","PXE","VDE","DRLL","BK4613","LU0006061336.USD","XES","GRFS","DBC","IXC","BK4139","DBE","EPV","SAP","BDRX","EQNR","IEO","LU0211326839.USD","SHEL","AKTX","BK4591","NOK","IEUR","PHG","CLLS","AMRN","SHEH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641438597","title":"European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2641438597","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641438597?lang=en_us&edition=fundamental","pubTime":"2026-06-08 23:10","pubTimestamp":1780931424,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, lifting 0.82% to 1,874.41 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biotech firm Evaxion , which rose 7% and 4.5% respectively. They were followed by accommodations booking company trivago  and telecommunications company Nokia , which increased 4.4% and 1.7% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and biopharmaceutical company Cellectis , which fell 2.9% and 2.3% respectively. They were followed by pharmaceutical company Sanofi  and biopharmaceutical company Grifols , which were down 2% each.The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals  and NuCana , which advanced 4.5% and 3.3% respectively. They were followed by oil and gas company BP  and biopharmaceutical company Amarin , which ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMRN","BK4588","BK4505","MREO","BK4020","GSKH","SNY","BK4547","IE00BZ1G4Q59.USD","CLLS","GSK.UK","LU1829250122.USD","NVOX","LU0162691827.USD","BP","NCNA","LU1162221912.USD","NGG","BK4532","LU0300736492.USD","NVOH","LU0072461881.USD","LU0320765646.SGD","BK4585","LU1093756325.SGD","IE00BMPRXR70.SGD","EVAX","BK4141","SQNS","AUTL","IE00BFXG1179.USD","LU0300736062.USD","BK4077","BK4007","LU1093756168.USD","LNOK","BK4208","BDRX","GRFS","BK4599","IE00BMPRXN33.USD","BK4201","GSK","LU0006061336.USD","NOK","LU0154236417.USD","TRVG","BPH","BK4139","IE00BKVL7J92.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641368149","title":"European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2641368149","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641368149?lang=en_us&edition=fundamental","pubTime":"2026-06-05 23:06","pubTimestamp":1780672000,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Friday morning, falling 0.85% to 1,882.19 on the S&P Europe Select ADR Index, which is up 0.9% for the week ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EPV","LU0300736492.USD","AKTX","DGE.UK","UL","CRTO","BTI","IE0002141913.USD","IE00BFMHRM44.USD","TRIB","LU1983260115.SGD","UN","BK4554","AFG","ARGX","ULVR.UK","DBVT","BK4075","LU0889565916.HKD","BK7507","IE00BMPRXR70.SGD","IE00BJT1NW94.SGD","IEUR","ERIC","LU0124676726.USD","BHP.AU","BK4009","BK4117","PSO","SLN","NOK","BK4141","LU0320765992.SGD","IE00BFTCPJ56.SGD","BTI.AU","BK4139","BK4559","LU0689626769.HKD","BK4591","SQNS","DEO","AUTL","BK4082","IE00B2B36J28.USD","LNOK","BHP","LU0109394709.USD","BK4169","CLLS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640884841","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2640884841","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640884841?lang=en_us&edition=fundamental","pubTime":"2026-06-03 23:10","pubTimestamp":1780499458,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were declining late Wednesday morning, falling 0.58% to 1,880.17 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia  and petroleum refiner Equinor , which rose 2.1% and 1.3%, respectively. They were followed by oil and gas company Eni  and biopharmaceutical company argenx , which were up 1% and 0.5%, respectively.The decliners from continental Europe were led by internet ad firm Criteo  and biopharmaceutical company Cellectis , which fell 7% and 4.7%, respectively. They were followed by biotech firm Evaxion  and software company SAP , which were down 4.6% and 4.5%, respectively.The gainers from the UK were led by Mereo BioPharma Group , which advanced 5.6%. It was followed by pharmaceutical company Silence Therapeutics  and medical device maker Smith & Nephew , which increased 4.8% and 2%, respectively.The decliners from the UK and Ireland were led by com","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1983260115.SGD","IE0009355771.USD","NCNA","ARGX","BK4505","MREO","BK4134","IE00B4R5TH58.HKD","BK4020","BCS","IE00BMPRXN33.USD","LU0109394709.USD","NOK","BK4585","BK4521","CLLS","IE0034235188.USD","LU2324357040.USD","DAVA.AU","BK4139","CRTO","LU0889565916.HKD","WPP","EVAX","IE0002141913.USD","IE00BMPRXR70.SGD","BK4201","BK4207","BK4588","EQNR","IEUR","IE00BFTCPJ56.SGD","BK4107","EPV","BK4009","IE00BFMHRM44.USD","SNN","E","AUTL","SAP","IE00B2B36J28.USD","SLN","AFG","LU0084288595.USD","WPP.AU","LNOK","BK4547","DAVA","IE00BJJMRZ35.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638692834","title":"European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2638692834","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638692834?lang=en_us&edition=fundamental","pubTime":"2026-05-28 23:14","pubTimestamp":1779981250,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending slightly lower late Thursday morning, declining 0.1% to 1,873.2 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet advertising firm Criteo  and medical device maker EDAP TMS , which rose 3.3% and 3.2% respectively. They were followed by biopharmaceutical company Cellectis  and software firm SAP , which were up 2.8% and 1.2% respectively.The decliners from continental Europe were led by telecommunications company Nokia  and brewing company Anheuser-Busch InBev , which fell 2.5% and 1.4% respectively. They were followed by biopharmaceutical company Grifols  and biotech firm BioNTech , which were down 1.1% and 0.3% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics  and biotech firm Autolus Therapeutics , which advanced 43.9% and 1.5% respectively. They were followed by communications company WPP  and biopharmaceutical compan","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLN","IEUR","LU0211326755.USD","LU0128525689.USD","AUTL","BK4107","BK4528","FOCL","HSBC","WPP","BK4535","LNOK","LU0310800965.SGD","BNTX","LU1267930227.SGD","BK4207","BK4009","EDAP","BUD","PUK","HSBH","WPP.AU","BK4158","LU2236285917.USD","BK4020","BK4551","AFG","BK4568","NOK","BK4023","BK4613","BK4588","BK7119","IE00BMPRXN33.USD","LU0976567544.SGD","CRTO","GRFS","BK4139","EPV","SAP","BDRX","BK4548","BUD.AU","LU0211326839.USD","AKTX","LU0052756011.USD","IE00BFMHRM44.USD","BK4585","CLLS","AMRN","LU0496365809.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638699951","title":"Cellectis Initiated at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2638699951","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638699951?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:46","pubTimestamp":1779975960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLLS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 28, 2026 09:46 ET (13:46 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637736568","title":"Press Release: Cellectis' Annual Shareholders General Meeting to be Held on June 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637736568","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637736568?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:30","pubTimestamp":1779309000,"startTime":"0","endTime":"0","summary":"NEW YORK, May 20, 2026  -- Cellectis  , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 25, 2026 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France.Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. The company utilizes an allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to develop gene therapies in other therapeutic indications. With its in-house manufacturing capabilities, Cellectis is one of the few end-to-end gene editing companies that controls the cell and gene therapy value chain from start to finish.Cellectis' headquarters are in Paris, France, with locations in New York an","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectis.com","stockEarnings":[{"period":"1week","weight":0.0289},{"period":"1month","weight":-0.05},{"period":"3month","weight":-0.2785},{"period":"6month","weight":-0.248},{"period":"1year","weight":0.0674},{"period":"ytd","weight":-0.4112}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.0292},{"period":"6month","weight":0.0719},{"period":"1year","weight":0.169},{"period":"ytd","weight":0.0876}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates. The company is developing ALLO-715 and ALLO-605 for the treatment of multiple myeloma; ALLO-501 to treat large B-cell lymphoma; ALLO-316, an allogeneic engineered CAR T-cell product targeting CD70; ALLO-819 to treat acute myeloid leukemia; ALLO-213 for the treatment of small cell lung cancer; and ALLO-182 to treat gastric and pancreatic cancer. It also develops UCART22 for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia; UCART123 to treat acute myeloid leukemia; UCART 20x22 for relapsed or refractory B-Cell non-hodgkin's lymphoma; and cema-cel to treat relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. The company has strategic alliances with Allogene Therapeutics, Inc. and Les Laboratoires Servier; research collaboration and exclusive license agreement with Iovance Biotherapeutics, Inc.; and joint research and collaboration, and investment agreement with AstraZeneca Holdings B.V., as well as with AstraZeneca Ireland Limited. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.025762},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.069977},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.047671},{"month":4,"riseRate":0.416667,"avgChangeRate":0.04499},{"month":5,"riseRate":0.583333,"avgChangeRate":0.041237},{"month":6,"riseRate":0.25,"avgChangeRate":-0.081754},{"month":7,"riseRate":0.333333,"avgChangeRate":0.033376},{"month":8,"riseRate":0.727273,"avgChangeRate":0.056431},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.108663},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.048106},{"month":11,"riseRate":0.545455,"avgChangeRate":0.268959},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.008306}],"exchange":"NASDAQ","name":"Cellectis SA","nameEN":"Cellectis SA","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectis SA(CLLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cellectis SA(CLLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cellectis SA,CLLS,Cellectis SA股票,Cellectis SA股票老虎,Cellectis SA股票老虎国际,Cellectis SA行情,Cellectis SA股票行情,Cellectis SA股价,Cellectis SA股市,Cellectis SA股票价格,Cellectis SA股票交易,Cellectis SA股票购买,Cellectis SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectis SA(CLLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cellectis SA(CLLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction